TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
QUIA PHARMA AB (publ)
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
![]() |
0
|
216 |
Financial expenses |
1,013
|
4,295
|
2,431 |
Earnings before taxes |
-16,523
|
-20,089
|
-20,000 |
EBITDA |
-11,653
|
-12,426
|
-15,367 |
Total assets |
41,959
|
23,442
|
23,764 |
Current assets |
1,764
|
3,762
|
6,291 |
Current liabilities |
26,708
|
5,823
|
6,720 |
Equity capital |
15,251
|
2,412
|
23 |
- share capital |
23,307
|
23,694
|
42,672 |
Employees (average) |
3
|
4
|
5 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
36.3%
|
10.3%
|
0.1% |
Turnover per employee |
0
![]() |
0
|
43 |
Profit as a percentage of turnover | -9259.3% | ||
Return on assets (ROA) |
-37.0%
|
-67.4%
|
-73.9% |
Current ratio |
6.6%
|
64.6%
|
93.6% |
Return on equity (ROE) |
-108.3%
|
-832.9%
|
-86956.5% |
Change turnover |
0
|
-216
|
-1,645 |
Change turnover % |
-100%
|
-88% | |
Chg. No. of employees |
-1
![]() |
-1
|
2 |
Chg. No. of employees % |
-25%
|
-20%
|
67% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.